Regeneron Pharmaceuticals (NQ: REGN )
1,051.81
-17.35
(-1.62%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Jun 27, 2024
Add to My Watchlist
All News about Regeneron Pharmaceuticals![]() ![]()
First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product
Today 9:49 EDT
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
Exposures
Product Safety
![]() ![]()
FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
May 31, 2024
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|